Results 131 to 140 of about 2,917 (283)
Knowing the Knowing. Non-dual Meditative Practice From an Enactive Perspective. [PDF]
Front Psychol, 2022 Meling D.
europepmc +1 more source
Journal of the Association for Information Science and Technology, EarlyView.Abstract User engagement (UE) has long been proposed as a holistic framework for understanding user‐technology interactions and a mediator for outcomes of digital technology use, such as learning, health behavior change, information acquisition, and social connectivity.
Heather L. O'Brien
wiley +1 more source
Journal of the Association for Information Science and Technology, EarlyView.Abstract Algorithmic platforms are reshaping how people work and how human activity is rendered intelligible within data‐intensive systems. This paper argues that Heidegger's philosophy of technology, specifically Ge‐stell (enframing) and Poiesis (bringing‐forth), offers information science a conceptual vocabulary for understanding both algorithmic ...
Fred Fonseca
wiley +1 more source
Autism Research, EarlyView.ABSTRACT Self‐determination has been assessed as an internal psychological construct. External factors may also affect self‐determination, but opportunities to make choices and decisions remain understudied. We developed and evaluated the AASPIRE‐Choices and Decisions Scale (AASPIRE‐CDS), a new measure of autistic adults' opportunities to make choices ...
So Yoon Kim +14 more
wiley +1 more source
British Journal of Clinical Pharmacology, EarlyView.Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden +3 more
wiley +1 more source
Zuranolone: A case study in (regulatory) rush to judgement?
British Journal of Clinical Pharmacology, EarlyView.Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove +4 more
wiley +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims GLP‐1 medicines provide substantial cardio‐renal benefits for type 2 diabetes (T2D) and are increasingly used for weight loss. Most high‐income countries subsidize access for T2D with restrictions; use outside of these restrictions occurs through private prescriptions. Despite strong consumer demand, the extent of private access to GLP‐1 medicines
Michael O. Falster +10 more
wiley +1 more source
Knowing Groundlessness: An Enactive Approach to a Shift From Cognition to Non-Dual Awareness. [PDF]
Front Psychol, 2021 Meling D.
europepmc +1 more source
The quality of interaction with children in collective play: Children's agency
British Educational Research Journal, EarlyView.Abstract There is a growing body of studies on increasing the quality of infant–toddler education and care. Yet little attention has been directed towards how to bring toddlers' agency and perspective to their personally meaningful learning in collective play.
Liang Li
wiley +1 more source